PL340920A1 - Heterocyclic compounds for inhibiting gastric juice secretion, method of obtaining them and pharmacological agents containing such compounds - Google Patents

Heterocyclic compounds for inhibiting gastric juice secretion, method of obtaining them and pharmacological agents containing such compounds

Info

Publication number
PL340920A1
PL340920A1 PL98340920A PL34092098A PL340920A1 PL 340920 A1 PL340920 A1 PL 340920A1 PL 98340920 A PL98340920 A PL 98340920A PL 34092098 A PL34092098 A PL 34092098A PL 340920 A1 PL340920 A1 PL 340920A1
Authority
PL
Poland
Prior art keywords
compounds
obtaining
gastric juice
pharmacological agents
agents containing
Prior art date
Application number
PL98340920A
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PL340920A1 publication Critical patent/PL340920A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL98340920A 1997-11-28 1998-11-18 Heterocyclic compounds for inhibiting gastric juice secretion, method of obtaining them and pharmacological agents containing such compounds PL340920A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704404A SE9704404D0 (sv) 1997-11-28 1997-11-28 New compounds
PCT/SE1998/002091 WO1999028322A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
PL340920A1 true PL340920A1 (en) 2001-03-12

Family

ID=20409181

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98340920A PL340920A1 (en) 1997-11-28 1998-11-18 Heterocyclic compounds for inhibiting gastric juice secretion, method of obtaining them and pharmacological agents containing such compounds

Country Status (32)

Country Link
US (1) US6518270B1 (enExample)
EP (1) EP1042324B1 (enExample)
JP (1) JP2001525322A (enExample)
KR (1) KR20010032559A (enExample)
CN (1) CN1142933C (enExample)
AR (1) AR016972A1 (enExample)
AT (1) ATE233263T1 (enExample)
AU (1) AU752187C (enExample)
BR (1) BR9814755A (enExample)
CA (1) CA2311798A1 (enExample)
CZ (1) CZ292349B6 (enExample)
DE (1) DE69811735T2 (enExample)
DK (1) DK1042324T3 (enExample)
EE (1) EE04060B1 (enExample)
ES (1) ES2191356T3 (enExample)
HU (1) HUP0100601A3 (enExample)
ID (1) ID24730A (enExample)
IL (1) IL136145A0 (enExample)
IS (1) IS5486A (enExample)
MY (1) MY121032A (enExample)
NO (1) NO315704B1 (enExample)
NZ (1) NZ504355A (enExample)
PL (1) PL340920A1 (enExample)
PT (1) PT1042324E (enExample)
RU (1) RU2241000C2 (enExample)
SE (1) SE9704404D0 (enExample)
SK (1) SK283904B6 (enExample)
TR (1) TR200001530T2 (enExample)
TW (1) TW515798B (enExample)
UA (1) UA70932C2 (enExample)
WO (1) WO1999028322A1 (enExample)
ZA (1) ZA9810468B (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025429A1 (en) 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
DE60017180T2 (de) 1999-10-08 2005-12-08 Affinium Pharmaceuticals, Inc., Toronto Fab i inhibitoren
CA2444597A1 (en) * 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
JP2003119140A (ja) * 2001-08-08 2003-04-23 Sankyo Co Ltd ピロロピリダジン化合物を含有する医薬
JP2005530739A (ja) 2002-04-19 2005-10-13 セルラー ジェノミクス，インコーポレーテッド イミダゾ［１，２−ａ］ピラジン−８−イルアミン、生成方法、および使用方法
WO2004022562A1 (en) 2002-09-09 2004-03-18 Cellular Genomics, Inc. 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
WO2004029058A1 (ja) * 2002-09-25 2004-04-08 Sankyo Company, Limited 血中ガストリン濃度上昇の抑制のための医薬組成物
WO2004029057A1 (ja) * 2002-09-25 2004-04-08 Sankyo Company, Limited 内臓痛の治療または予防のための医薬組成物
AU2003298937A1 (en) * 2002-12-06 2004-06-30 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
WO2004072081A1 (en) 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
CA2519429C (en) * 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US7405295B2 (en) 2003-06-04 2008-07-29 Cgi Pharmaceuticals, Inc. Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
WO2005005429A1 (en) 2003-06-30 2005-01-20 Cellular Genomics, Inc. Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
US7259164B2 (en) 2003-08-11 2007-08-21 Cgi Pharmaceuticals, Inc. Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
US8450307B2 (en) * 2004-06-04 2013-05-28 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
WO2006011670A1 (ja) * 2004-07-28 2006-02-02 Takeda Pharmaceutical Company Limited ピロロ［２，３－ｃ］ピリジン化合物、その製造方法および用途
AU2005268767A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1H-pyrrolo[3,2-B]pyridines
CA2579127C (en) 2004-09-03 2011-08-02 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
JP5126830B2 (ja) 2004-09-03 2013-01-23 ユーハン・コーポレイション ピロロ［３，２−ｃ］ピリジン誘導体及びその製造方法
RU2375359C2 (ru) * 2004-09-03 2009-12-10 Юхан Корпорейшн ПРОИЗВОДНЫЕ ПИРРОЛО[3, 2-c]ПИРИДИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
US7662832B2 (en) 2004-09-03 2010-02-16 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
US7777040B2 (en) 2005-05-03 2010-08-17 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
TW200800213A (en) 2005-09-02 2008-01-01 Abbott Lab Novel imidazo based heterocycles
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
US7557104B2 (en) 2006-06-06 2009-07-07 Schering Corporation Imidazopyrazines as protein kinase inhibitors
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
JP5496915B2 (ja) 2008-02-13 2014-05-21 シージーアイ ファーマシューティカルズ，インコーポレーテッド ６−アリール−イミダゾ［１，２−ａ］ピラジン誘導体、その製造方法、及びその使用方法
EP3123864A1 (en) 2008-12-08 2017-02-01 Gilead Connecticut, Inc. Imidazopyrazine syk inhibitors
US8450321B2 (en) 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
EP3552607A3 (en) 2008-12-08 2020-01-15 Gilead Connecticut, Inc. Imidazopyrazine syk inhibitors
US9562056B2 (en) 2010-03-11 2017-02-07 Gilead Connecticut, Inc. Imidazopyridines Syk inhibitors
DK2861608T3 (da) 2012-06-19 2019-06-24 Debiopharm Int Sa Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid
KR101810798B1 (ko) 2013-07-30 2017-12-19 질레드 코네티컷 인코포레이티드 Ｓｙｋ 억제제의 다형체
PT3027171T (pt) 2013-07-30 2020-06-18 Gilead Connecticut Inc Formulação de inibidores da syk
KR20180002888A (ko) 2013-12-04 2018-01-08 길리애드 사이언시즈, 인코포레이티드 암을 치료하는 방법
GB201321738D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
TWI735853B (zh) 2013-12-23 2021-08-11 美商克洛諾斯生技有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
KR20170029580A (ko) 2014-07-14 2017-03-15 길리애드 사이언시즈, 인코포레이티드 암을 치료하기 위한 조합물
BR112018016721A2 (pt) 2016-02-26 2018-12-26 Debiopharm Int Sa uso de di-hidrogeno fosfato de {6-[(e)-3-{metil[(3-metil-1-benfofuran-2-iol)metil]amino)-3-xopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)-il}metila e composição farmacêutica para tratamento de infecções bacterianas associadas ao pé diabético
KR20220070056A (ko) 2017-08-25 2022-05-27 길리애드 사이언시즈, 인코포레이티드 Syk 억제제의 다형체
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
JP2022521413A (ja) 2019-02-22 2022-04-07 クロノス バイオ インコーポレイテッド Ｓｙｋ阻害剤としての縮合ピラジンの固体形態
CA3139942A1 (en) 2019-06-14 2020-12-17 Justyna NOWAKOWSKA Medicament and use thereof for treating bacterial infections involving biofilm

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507294A (en) 1982-03-08 1985-03-26 Schering Corp. Imidazo[1,2-a]pyrazines
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
IL97931A0 (en) 1990-04-27 1992-06-21 Byk Gulden Lomberg Chem Fab Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5041442A (en) 1990-07-31 1991-08-20 Syntex (U.S.A.) Inc. Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
AU8712191A (en) * 1990-10-15 1992-05-20 Byk Gulden Lomberg Chemische Fabrik Gmbh New diazines
DK0609328T3 (da) 1991-10-25 1999-10-25 Byk Gulden Lomberg Chem Fab Pyrrolo-pyridaziner med gastro-intestinal beskyttelsesvirkning
ATE229020T1 (de) 1994-01-19 2002-12-15 Sankyo Co Pyrrolopyridazin-derivate
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9700661D0 (sv) 1997-02-25 1997-02-25 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds

Also Published As

Publication number Publication date
HK1030216A1 (en) 2001-04-27
CZ20001947A3 (cs) 2000-11-15
NO20002721D0 (no) 2000-05-26
KR20010032559A (ko) 2001-04-25
HUP0100601A2 (hu) 2001-09-28
EE200000315A (et) 2001-10-15
NZ504355A (en) 2001-12-21
RU2241000C2 (ru) 2004-11-27
ID24730A (id) 2000-08-03
DE69811735T2 (de) 2003-12-18
AU752187B2 (en) 2002-09-12
EP1042324A1 (en) 2000-10-11
JP2001525322A (ja) 2001-12-11
TR200001530T2 (tr) 2000-11-21
US6518270B1 (en) 2003-02-11
NO20002721L (no) 2000-07-28
AU752187C (en) 2003-09-18
BR9814755A (pt) 2000-10-03
EE04060B1 (et) 2003-06-16
SK283904B6 (sk) 2004-04-06
TW515798B (en) 2003-01-01
EP1042324B1 (en) 2003-02-26
NO315704B1 (no) 2003-10-13
CN1142933C (zh) 2004-03-24
ZA9810468B (en) 1999-05-21
IS5486A (is) 2000-05-10
CA2311798A1 (en) 1999-06-10
IL136145A0 (en) 2001-05-20
WO1999028322A1 (en) 1999-06-10
CN1284078A (zh) 2001-02-14
MY121032A (en) 2005-12-30
DE69811735D1 (de) 2003-04-03
SK6742000A3 (en) 2001-03-12
ATE233263T1 (de) 2003-03-15
PT1042324E (pt) 2003-06-30
DK1042324T3 (da) 2003-05-05
UA70932C2 (uk) 2004-11-15
ES2191356T3 (es) 2003-09-01
HUP0100601A3 (en) 2002-10-28
CZ292349B6 (cs) 2003-09-17
SE9704404D0 (sv) 1997-11-28
AU1356599A (en) 1999-06-16
AR016972A1 (es) 2001-08-01

Similar Documents

Publication Publication Date Title
PL340920A1 (en) Heterocyclic compounds for inhibiting gastric juice secretion, method of obtaining them and pharmacological agents containing such compounds
PL335485A1 (en) Compounds inhibiting secretion of gastric juice
PL331856A1 (en) Heterocyclic inhibitors of metaloprotease
PL299176A1 (en) Novel heterocyclic compounds, pharmaceutical agent, method of obtaining such novel heterocyclic compounds and initial compounds for obtaining them
HUP0105174A3 (en) Heterocyclic inhibitors of p38, process for their preparation and medicaments containing them
EG24291A (en) Novel form of s-omeprazole
PL339292A1 (en) Derivatives of carboxyaamidathiazoles, method of obtaining and pharmacological compositions containing them
PL327943A1 (en) Condensed heterocyclic derivatives of morphonoide (ii)
PL331795A1 (en) Heterocyclic metaloprotease inhibitors
PL330841A1 (en) Benzosulphonic derivatives, method of obtaining them and therapeutic agents containing such derivatives
ZA98643B (en) Method for inhibiting the growth of cancers
SG74729A1 (en) Method of forming bumps
PL323968A1 (en) Novel heterocyclic compounds, method of obtaining them, their application as medicines and pharmaceutic agent
HUP0003737A3 (en) New process for the preparation of omeprazole
GB9603213D0 (en) Ureido derivatives og substituted heterocyclic compounds and process for their preparation
IL134991A0 (en) Method for the synthesis of quinoline derivatives
HUP0003127A3 (en) Substituted heterocyclic compounds, method for preparing and compositions containing same
PL333984A1 (en) Method of obtaining n-substituted 3-hydroxypyrazoles
HU9902691D0 (en) Process for re-esterification of alfa-keto-carboxylic-acid-esters
HUP9903744A3 (en) Method of omeprazole preparation
PL337690A1 (en) Method of obtaining 4-substituted 1h-indolo-3-glyoxamides
PL330517A1 (en) Novel heterocyclic compounds, method of obtaining them and pharmaceutic compositions containing such compounds
PL329117A1 (en) Method of obtaining fluconazole
IL117995A0 (en) Process for making heterocyclic compounds
PL329053A1 (en) Novel derivatives of oxazolydine, method of obtaining them and therapeutic agents containing such compounds

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)